CEVAMEDIUM SIGNALFINANCIAL10-K

CEVA showed solid revenue growth but widening operating losses amid expanding business operations.

The company demonstrated meaningful revenue expansion while absorbing higher operating expenses that outpaced top-line growth, resulting in deeper operating losses. The substantial increase in current assets and stockholders' equity suggests the company is investing in growth initiatives while maintaining a strengthened balance sheet position.

Comparing 2026-02-27 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

CEVA delivered robust revenue growth of 20% while operating losses widened meaningfully from $7.5M to $11.3M as expenses grew faster than sales. The balance sheet showed considerable strength with current assets expanding 32% and stockholders' equity rising 26%, indicating the company is well-capitalized to support its growth investments. The increase in accounts receivable aligned with revenue growth, suggesting healthy business expansion rather than collection issues.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-50.4%
-$7.5M-$11.3M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Accounts Receivable
Balance Sheet
+32.6%
$37.2M$49.4M

Receivables surged 32.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Current Assets
Balance Sheet
+31.7%
$216.3M$284.8M

Current assets grew 31.7% — improving short-term liquidity or inventory/receivables build.

Stockholders Equity
Balance Sheet
+26.2%
$266.6M$336.5M

Equity base grew 26.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+25.7%
$308.9M$388.3M

Asset base grew 25.7% — expansion through organic growth, acquisitions, or capital deployment.

Net Income
P&L
-21.1%
-$8.8M-$10.6M

Net income declined 21.1% — review whether driven by operations, interest costs, or non-recurring items.

Revenue
P&L
+20.4%
$72.7M$87.5M

Revenue growing 20.4% — solid top-line momentum, watch margins for quality of growth.

Share Buybacks
Cash Flow
-15.4%
$8.5M$7.2M

Buyback activity reduced 15.4% — capital being redeployed elsewhere or cash conservation underway.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-27
ADDED
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 55 Item 13.
In some cases, you can identify forward-looking statements by terms such as may, will, should, could, goal, would, expect, plan, anticipate, believe, estimate, project, predict, potential, and similar expressions intended to identify forward-looking statements.
These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements.
We discuss these risks, uncertainties and other factors in this Annual Report in greater detail under Part I Item 1A Risk Factors.
Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements.
+7 more — sign up free →
REMOVED
Security Ownership of Certain Beneficial Owners and Management and Related Stock Holder Matters 56 Item 13.
All statements other than statements of historical fact are statements that could be deemed forward-looking statements.
Forward-looking statements are generally written in the future tense and/or are preceded by words such as will, may, should, could, expect, suggest, believe, anticipate, intend, plan, or other similar words.
Forward-looking statements are not guarantees of future performance and involve risks and uncertainties.
The forward-looking statements contained in this report are based on information that is currently available to us and expectations and assumptions that we deem reasonable at the time the statements were made.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →